首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Real-time monitoring of breath ammonia during haemodialysis: Use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques
【24h】

Real-time monitoring of breath ammonia during haemodialysis: Use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques

机译:血液透析期间实时监测呼吸中的氨气:使用离子迁移谱(IMS)和腔衰荡光谱(CRDS)技术

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background The diffusion of high-performance analytical technology has opened prospects for breath diagnosis as a non-invasive diagnostic tool. In this study, ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques were used to analyse ammonia gas (NH3) in real-time in breath from patients undergoing haemodialysis (HD) treatment and any correlation with blood urea nitrogen (BUN) levels and Kt/V were investigated. Methods We studied 20 patients on intermittent HD treatment. The first breath samples were taken before the start of dialysis and further breath samples were taken every hour during the treatment and after the end of the session. An evaluation was also made of 20 healthy volunteers, acting as controls [healthy subjects (HS)]. Results Breath ammonia concentrations were higher in CRDS-HD (914.5 ± 301.4 versus 280 ± 120 parts per billion (p.p.b.), P < 0.0001) and IMS-HD patients (964.4 ± 402.4 versus 280 ± 120 p.p.b., P < 0.0001) than in HS. We assessed real-time variations in the levels of NH3 and showed a continuous decrease in the levels of NH3. Expired NH3 correlated directly with BUN levels, both in the IMS-HD (P = 0.002; r = 0.84; P = 0.009; r = 0.76) and in the CRDS-HD group (P = 0.005; r = 0.80; P = 0.008; r = 0.77), respectively, both before and at the end of dialysis. A direct correlation with Kt/V was found in both groups studied (IMS-HD: P = 0.003; r = 0.82; CRDS-HD: P = 0.006; r = 0.79). Conclusions Breath monitoring of NH3 with IMS and CRDS techniques could be useful to assess the real-time clinical status of patients during HD. By using pre-dialysis ammonia values, an approximate calculation of the Kt/Vurea ratio can be established.
机译:背景技术高性能分析技术的普及为呼吸诊断作为一种非侵入性诊断工具开辟了前景。在这项研究中,离子迁移谱(IMS)和腔衰荡光谱(CRDS)技术用于实时分析接受血液透析(HD)治疗的患者的呼吸中的氨气(NH3)以及与血液尿素氮的任何相关性(BUN)水平和Kt / V进行了调查。方法我们研究了20例间歇性HD治疗患者。在透析开始前采集第一次呼吸样品,在治疗期间和疗程结束后每小时采集一次进一步的呼吸样品。还对20名健康志愿者作为对照[健康受试者(HS)]进行了评估。结果CRDS-HD患者(914.5±301.4 vs 280±120 ppb(ppb),P <0.0001)和IMS-HD患者的呼吸氨浓度较高(964.4±402.4 vs 280±120 ppb,P <0.0001)。 HS。我们评估了NH3含量的实时变化,并显示了NH3含量的持续下降。在IMS-HD(P = 0.002; r = 0.84; P = 0.009; r = 0.76)和CRDS-HD组(P = 0.005; r = 0.80; P = 0.008)中,过期的NH3与BUN水平直接相关。 ; r = 0.77),分别在透析前后和透析结束时。在两组研究中均发现与Kt / V有直接相关性(IMS-HD:P = 0.003; r = 0.82; CRDS-HD:P = 0.006; r = 0.79)。结论IMS和CRDS技术对呼吸道中的NH3进行监测可能有助于评估HD患者的实时临床状况。通过使用透析前的氨值,可以建立Kt / Vurea比的近似计算。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号